Urania Dafni (Sc.D, Harvard School of Public Health), is Professor of Biostatistics at the University of Athens, and Director of Frontier Science Foundation – Hellas. She is the Statistics Track Chair of the Lungscape Steering Committee for the European Thoracic Oncology Platform (ETOP) (2011- ), and the ETOP Group Statistician. She serves as an International Biometric Society (IBS) Education Committee member (2010-2016), ESMO Faculty member for Principles Trials and Systemic Therapy (2012-2015), and ASCO Scientific Program Committee member (2013-2016). She has been one of the founding members of the Eastern Mediterranean Region of IBS (EMR-IBS; 2001) and President of EMR-IBS (2005-2007). She has served as Biometric Bulletin Editor for IBS (2005-2008; 2008 Recognition Award), Editorial Representative and member of the Executive Committee of IBS (2007-2011). She was the Scientific Director of the National Syndromic Surveillance program for the Athens 2004 Olympic Games and is currently a member of the Board of Directors of the Hellenic Center for Disease Control and Prevention (HCDCP), Ministry of Health (2015-2018). She has participated as member of the IDMC or as senior statistician in numerous Clinical Trials, mainly in Cancer, AIDS, and auto-immune diseases and her research interests include surrogate markers, multivariate count data, adaptive trial design and methods accounting for crossover. She has been a member of the organizing and/or scientific committee of international conferences (XXIIIrd IBS International Conference, 2006; International Society for Clinical Biostatistics - ISCB28, 2007), chair of the 3rd EMR-IBS conference (2005), and organizer or invited lecturer in numerous Biostatistics and Oncology workshops/seminars. She is a member of the international advisory committee of the National Spanish Network of Biostatistics (Biostat Net, 2011 - 2015). She is currently the Statistics Editor of the Lung Cancer journal, and has over 110 peer-reviewed publications (J Clin Oncol, J Thorac Oncol, Ann Oncol, Lancet Oncol, NEJM, J Breast Cancer Res Treat, Cancer, Arthritis Rheum, JIntern Med, Control Clin Trials, MMWR, Circ Cardiovasc Qual Outcomes, Biometrics, JASA).

Record last modified Aug 4, 2018 7:18:47 PM